Last updated on September 2014

Study for Type 2 Diabetic subjects with high risk of cardiovascular events.


Brief description of study

Study for Type 2 Diabetic subjects with high risk of cardiovascular events.

Detailed Study Description

This clinical trial compares insulin degludec to insulin glargine in type 2 diabetic patients with high risk of cardiovascular events. All subjects receive active medication-there is no placebo.

Clinical Study Identifier: TX139224

Find a site near you

Start Over

Tampa Clinical Research

4278 W. Linebaugh Avenue Tampa, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.